Andrew Wakefield and Measles Vaccinations
Andrew Wakefield and Measles Vaccinations
Everybody Knows
Most people know that Andrew Wakefield falsified data from his measles vaccines studies and that his 1998 article on autism and gastrointestinal disease was retracted by The Lancet as it deceitfully showed that a link between measles vaccines and autism. 1
Everyone knows that the link with vaccination and autism has been thoroughly discredited. However, as a result of Wakefield’s discredited research, parents still believe in the link between autism and vaccination and as a result millions of children are denied life-saving vaccinations by irresponsible parents.
Wakefield subsequently had his licence to practice medicine in the UK revoked.
Biography
Andrew Wakefield received his medical degree from St. Mary’s Hospital Medical School, which is part of the University of London, in 1981. He specialised in gastrointestinal surgery and inflammatory bowel disease. He qualified as Fellow of the Royal College of Surgeons in 1985. He has published over 140 scientific articles. 64 2
Previous Studies Related to Measles Vaccination
A paper published in 1995 reached the following conclusion. 3
Compared with the birth cohort, the relative risk of developing Crohn’s disease in the vaccinated group was 3·01 (95% Cl 1·45-6·23) and of developing ulcerative colitis was 2·53 (1·15-5·58). There was no significant difference between these two groups in coeliac disease prevalence.
What Really Happened
In the early 1990s, Dr. Wakefield began to study a possible link between the measles virus and bowel disease. He published a 1993 study, Evidence of persistent measles virus infection in Crohn’s disease 65 4
Wakefield co-authored a 1995 article published in The Lancet, Is measles vaccine a risk factor for inflammatory bowel disease? 66 5
On February 28, 1998, Wakefield and 12 colleagues published a paper in the Lancet, as an Early Report. The paper described the clinical findings in 12 children with chronic enterocolitis and severe regressive developmental disorder.
The children, aged between 3 to 10, were referred to a paediatric gastroenterology unit headed by Professor John Walker-Smith, with a history of normal development followed by loss of acquired skills, including language, together with diarrhoea and abdominal pain.
Professor Walker-Smith, one of the world’s leading pediatric gastroenterologists and senior author of The Lancet paper, wrote in 1997 that,
The parents (not Wakefield or the other 12 authors) associated the behavioural changes with measles, mumps and rubella [MMR] vaccination in eight of the 12 children, with measles infection in one child, and otitis media [middle ear inflammation] in another.
It was later revealed that the parents who indicated otitis media also associated the changes with MMR vaccination. Because of the hostility it caused when discussing their child’s condition with the medical profession, they decided not to mention vaccination.
The conslusion that Wakefield’s 1998 paper raised the issue of developmental behavioral concerns resulting in the scare campaign is clearly false as the parents decided not to mention vaccination prior to visiting Wakefield.
The conclusion of the paper was that the,
News Conference
Prior to the publication of the paper in The Lancet on 28th February 1998, Wakefield raised concerns regarding the safety of the MMR vaccine.
He compiled a 250 page report and as a result concluded that,
This was announced at a press conference prior to the paper’s publication. The UK government withdraw the licence to use single vaccines six months later in September.
Recall that MMR vaccine containing the Urabe strain of mumps virus had already been withdrawn in 1992 following serious safety concerns in Japan and Canada because it caused meningitis.
The editor of The Lancet, Richard Horton, asked that the authors issue a partial retraction of the interpretation that MMR vaccine causes autism.
Three of the 13 authors said no.
The Charges Against Wakefield by the General Medical Council
The General Medicine Council (GMC) made the following charges against Wakefield. 67
- Dr. Wakefield was paid 55,000 British pound sterling (about US $90,000) by litigators for the study published in The Lancet, and he failed to disclose this conflict of interest;
- He and his colleagues performed medically unnecessary tests on the children in the 1998 study and lacked appropriate ethical clearances;
- The children in the 1998 study were selected for litigation purposes (as described in the Sunday Times article) and not referred by local physicians; and
- He drew blood from children at his son’s birthday party for control samples in the 1998 study with callous disregard for the distress that this might cause children.
At no stage was there any allegations by the GMC that data has been fabricated.
Falsification of Data
The ony data included in the paper was results for vitamin B12 and urinary methylmalonic acid [MMA]. Inflammatory bowel disease and Crohn’s disease has been associated with vitamin b12 [cobalamin]. MMA is a more reliable test for the determining the status of vitamin B12. 6
It was a journalist Brian Deer who first suggested that the data was fabricated six years after the article was published. Apparently it escaped the attention of all other including the parents, co-authors, the medical department, reviewers and readers.
Not even the General Medical Council who bought the charges of malpractice against Wakefield and the two other authors who refused to retract their findings because “there was nothing to retract”.
Failure to Disclose Payment from Litigators
Dr. Wakefield accepted 55,000 pounds to conduct a study for the class action suit regarding vaccines and autism. This was a research grant from which Dr. Wakefield personally received no compensation. Dr. Wakefield did not start this study until after the case series for the Lancet 12 had been submitted.
Legal documents prove that Dr. Wakefield’s hospital knew about this study and knew about the amount of money he received, most of which went to pay the salary of a designated laboratory technician. Documents further demonstrate that Dr. Wakefield disclosed in a national newspaper over one year before publication of the 1998 article that he was working with the litigators.
Horton, editor of The Lancet, had been informed and was aware of Dr. Wakefield’s role in the vaccine-related litigation before the publication of the 1998 article.
Medical Necessity and Ethical Clearances
The Lancet 12 were very unwell.
Each child was administered tests with the intent to aid that child. The hospital administration was fully aware of the tests being conducted and made no objections. Because all of the tests were “clinically indicated” and not for research purposes, no ethical clearance beyond what Prof. Walker Smith already possessed was required. Notably, no patient, parent, or guardian has ever made accusations against Dr. Wakefield or testified against him for ethical violations or medically unnecessary procedures. Dr. Wakefield and his colleagues rejected the GMC’s ruling that the tests for the Lancet 12 were unnecessary.
The Lancet 12’s Referrals
The General Medical Council charged that the children were referred through the litigation effort and not through ordinary medical channels. This is incorrect. Parents started contacting Dr. Wakefield long before the litigation started, and independently of it. Since the litigation study was not yet started by the time The Lancet study was completed and submitted to the journal, this finding is false. Dr. Wakefield and his colleagues reject that claim; the families contacted them directly because of their medical expertise.
Control Blood Samples from a Child’s Birthday Party
Dr. Wakefield arranged for control blood samples from healthy, typically developing children to be taken at his son’s birthday party. Most of the children’s parents were medical colleagues and friends. He did this with the children’s and parents’ fully informed consent and gave the children 5 pounds each for their trouble. The procedure was undertaken by an appropriately qualified doctor using a standard technique. The children were happy to be helpful and went on to enjoy the birthday party.
Retraction of the 1998 Lancet Article
The Lancet published the following retraction on 2nd February 2010.
Following the judgement of the UK General Medical Council’s Fitness to Practise Panel on Jan 28, 2010, it has become clear that several elements of the 1998 paper by Wakefield et al1 are incorrect, contrary to the findings of an earlier investigation. In particular, the claims in the original paper that children were “consecutively referred” and that investigations were “approved” by the local ethics committee have been proven to be false. Therefore we fully retract this paper from the published record. 68
In the High Court case that exonerated John Walker-Smith, Justice Mitting ruled that the Lancet children were consecutively referred and that medical procedures used in the study, including lumbar punctures and endoscopic biopsies, were clinically indicated and therefore did not require approval from an ethics committee.
A statement by The Royal Free and University College Medical School and The Royal Free Hampstead NHS Trust
The Vice-Dean and campus director of Royal Free and University College School, Professor Humphrey Hodgson, wrote to The Lancet editors in 2004 stating:
The editors rejected this review by the campus director of the medical school where the children were treated. They found another reviewer that rejected the above review without giving any explanations on the reasons.
The hypothesis that the inability of the intestines to absorb nutrients, in particular, vitamin B12, vitamin C and folate may contribute to the severity of the symptoms of the 12 patients being treated.
These dietary interventions help in treating inflammatory bowel disease and subsequently did provide substantial help when given the opportunity. 7 ~ 8 ~ 9
The High Court Ruling
Professor John Walker-Smith contested each and every finding made by the General Medical Council in the High Court. Justice John Mitting, overturned all of the panel’s findings with respect to Walker-Smith.
Justice Mitting concluded that the panel made “fundamental errors,” “distorted evidence” and based its findings on an inadequate analysis of the facts. GMC provided “inadequate and superficial reasoning and explanation for its conclusions”, “inappropriately rejected evidence”, relied upon “flawed” and “wrong” reasoning and made “numerous and significant inadequacies” in its conclusions.
Justice Mitting described the panel’s findings as “not legitimate,” “perverse,” “odd”, “wrong,” “unsustainable,” and “untenable.”
Justice Mitting ruled that the Lancet children were consecutively referred and that medical procedures used in the study, including lumbar punctures and endoscopic biopsies, were clinically indicated and therefore did not require approval from an ethics committee.
| Table 1 | |||||
|---|---|---|---|---|---|
| Child | Age (years) | Sex | Abnormal laboratory tests | Endoscopic findings | Histological findings |
| 1 | 4 | M | Hb 10·8, PCV 0·36, WBC 16·6 (neutrophilia), lymphocytes 1·8, ALP 166 | Ileum not intubated; aphthoid ulcer in rectum | Acute caecal cryptitis and chronic non-specific colitis |
| 2 | 9.5 | M | Hb 10·7 | LNH of T ileum and colon; patchy loss of vascular pattern; caecal aphthoid ulcer | Acute and chronic non-specific colitis: reactive ileal lymphoid hyperplasia |
| 3 | 7 | M | MCV 74, platelets 474, eosinophils 2·68, IgE 114, IgG1 8·4 | LNH of T ileum | Acute and chronic non-specific colitis: reactive ileal and colonic lymphoid hyperplasia |
| 4 | 10 | M | IgE 69, IgG1 8·25, IgG4 1·006, ALP 474, AST 50 | LNH of T ileum; loss of vascular pattern in rectum | Chronic non-specific colitis: reactive ileal and colonic lymphoid hyperplasia |
| 5 | 8 | M | LNH of T lieum; proctitis with loss of vascular pattern | Chronic non-specific colitis: reactive ileal lymphoid hyperplasia | |
| 6 | 5 | M | Platelets 480, ALP 207 | LNH of T ileum; loss of colonic vascular pattern | Acute and chronic non-specific colitis: reactive ileal lymphoid hyperplasia |
| 7 | 3 | M | Hb 9·4, WBC 17·2 (neutrophilia), ESR 16, IgA 0·7 | LNH of T ileum | Normal |
| 8 | 3.5 | F | IgA 0·5, IgG 7 | Prominent ileal lymph nodes | Acute and chronic non-specific colitis: reactive ileal lymphoid hyperplasia |
| 9 | 6 | M | LNH of T ileum; patchy erythema at hepatic flexure | Chronic non-specific colitis: reactive ileal and colonic lymphoid hyperplasia | |
| 10 | 4 | M | IgG1 9·0 | LNH of T ileum and colon | Chronic non-specific colitis: reactive ileal lymphoid hyperplasia |
| 11 | 6 | M | Hb 11·2, IgA 0·26, IgM 3·4 | LNH of T ileum | Chronic non-specific colitis |
| 12 | 7 | M | IgA 0·7 | LNH on barium follow-through;colonoscopy normal; ileum not intubated | Chronic non-specific colitis: reactive colonic lymphoid hyperplasia |
| LNH=lymphoid nodular hyperplasia; T ileum=terminal ileum. Normal ranges and units: Hb=haemoglobin 11·5–14·5 g/dL; PCV=packed cell volume 0·37–0·45; MCV=mean cell volume 76–100 pg/dL; platelets 140–400 109/L; WBC=white cell count 5·0–15·5 109/L; lymphocytes 2·2–8·6 109/L; eosinophils 0–0·4 109/L; ESR=erythrocyte sedimentation rate 0–15 mm/h; IgG 8–18 g/L; IgG1 3·53–7·25 g/L; IgG4 0·1–0·99 g/L; IgA 0·9–4·5 g/L; IgM 0·6–2·8 g/L; IgE 0–62 g/L; ALP=alkaline phosphatase 35–130 U/L; AST=aspartate transaminase 5–40 U/L. | |||||
| Table 2 | Symptom | |||||
|---|---|---|---|---|---|---|
| Child | Behavioural diagnosis | Exposure identified by parent or doctor | Interval from exposure to first behavioural symptom | Features associated with exposure | Behaviour | Bowel |
| 1 | Autism | MMR | 1 week | Fever / delirium | 12 months | Not known |
| 2 | Autism | MMR | 2 weeks | Self injury | 13 months | 20 months |
| 3 | Autism | MMR | 48 hours | Rash and fever | 14 months | Not known |
| 4 | Autism? Disintegrative disorder? | MMR | Measles vaccine at 15 months followed by slowing in development. Dramatic deterioration in behaviour immediately after MMR at 4·5 years | Repetitive behaviour, self injury, loss of self-help | 4.5 years | 18 months |
| 5 | Autism | None - MMR at 16 months | Self-injurious behaviour started at 18 months | 4 years | 2 years | |
| 6 | Autism | MMR | 1 week | Rash & convulsion; gaze avoidance & self injury | 15 months | 19 months |
| 7 | Autism | MMR | 48 hours | Convulsion, gaze avoidance | 21 months | 2.5 years |
| 8 | Post-vaccinial encephalitis? | MMR | 2 weeks | Disinterest; lack of play | 19 months | 19 months |
| 9 | Autistic spectrum disorder | Recurrent otitis media | 1 week (MMR 2 months previously) | Fever, rash & vomiting | 18 months | 2.5 years |
| 10 | Post-viral encephalitis? | Measles (previously vaccinated with MMR) | 24 hours | Recurrent “viral pneumonia”for 8 weeks following MMR | 15 months | Not known |
| 11 | Autism | MMR | 1 week | 15 months | Not known | |
| 12 | Autism | None - MMR at 15 months | Loss of speech development and deterioration in language skills noted at 16 months | Not known | ||
For a much more complete explanation of the events involving the 1998 Lancet paper, read the following book.
Wakefield, A. (2017). Callous Disregard: Autism and Vaccines—The Truth Behind the Tragedy. Skyhorse Publishing.
Last updated on Wednesday 18 November 2026 at 21:20 by administrators
Post Type: pageFootnotes
- Wakefield, A. et al. (1998) RETRACTED: Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. The Lancet. 351 (9103), 637–641.
- Wakefield, Andrew J. (2010) Callous Disregard: Autism and Vaccines: The Truth Behind a Tragedy.
- Thompson, N. P. et al. (1995) Is measles vaccination a risk factor for inflammatory bowel disease? The Lancet. 345 (8957), 1071–1074.
- Wakefield, A. J. et al. (1993) Evidence of persistent measles virus infection in Crohn’s disease. Journal of Medical Virology. 39 (4), 345–353.
- Thompson, N. P. et al. (1995) Is measles vaccination a risk factor for inflammatory bowel disease? The Lancet. 345 (8957), 1071–1074.
- Wakefield, Andrew J. Callous Disregard: Autism and Vaccines: The Truth Behind a Tragedy Skyhorse Publishing.
- Yakut, M. et al. (2010) Serum vitamin B12 and folate status in patients with inflammatory bowel diseases. European Journal of Internal Medicine. 21 (4), 320–323.
- Pan, Y. et al. (2017) Associations between Folate and Vitamin B12 Levels and Inflammatory Bowel Disease: A Meta-Analysis. Nutrients. 9 (4), 382.
- Akbulut, S. (2022) An assessment of serum vitamin B12 and folate in patients with Crohn’s disease. Medicine. 101 (50), e31892.





